Computer and Scientific

Owner

REPLIMUNE LIMITED

—

Computer and Scientific

Owner

REPLIMUNE LIMITED

—
TDOI

Pharmaceuticals and 2 other

Owner

REPLIMUNE LIMITED

—
RP3

Pharmaceuticals and 2 other

Owner

REPLIMUNE LIMITED

—
RP2

Pharmaceuticals and 2 other

Owner

REPLIMUNE LIMITED

—
RP1

Pharmaceuticals and 2 other

Owner

REPLIMUNE LIMITED

—
TUMOR-DIRECTED ONCOLYTIC IMMUNOTHERAPIES

Pharmaceuticals and 2 other

Owner

REPLIMUNE LIMITED

—
DEVELOPING THE 'ON' SWITCH FOR IMMUNO-ONCOLOGY

Pharmaceuticals and 2 other

Owner

REPLIMUNE LIMITED

Mar 19, 2019
PROVIDING THE 'ON' SWITCH FOR IMMUNO-ONCOLOGY

Pharmaceuticals and 2 other

Owner

REPLIMUNE LIMITED

Jul 17, 2018

Pharmaceuticals and 2 other

Owner

REPLIMUNE LIMITED

Aug 14, 2018
REPLIMUNE

Pharmaceuticals and 2 other

Owner

REPLIMUNE LIMITED

Dec 12, 2017
IMMULYTIC

Pharmaceuticals

Owner

REPLIMUNE LIMITED

Dec 12, 2017
IMULYTIC

Pharmaceuticals

Owner

REPLIMUNE LIMITED

Dec 12, 2017